{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:21:58Z","timestamp":1787628118113,"version":"build-2736575974"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/13696998.2023.2290832","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T03:52:25Z","timestamp":1701834745000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8525-9641","authenticated-orcid":false,"given":"Olalekan O.","family":"Oluwole","sequence":"first","affiliation":[{"name":"Vanderbilt University Medical Centre","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Kite, a Gilead company","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Vadgama","sequence":"additional","affiliation":[{"name":"Kite, a Gilead company","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Maple Health Group","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Blissett","sequence":"additional","affiliation":[{"name":"Maple Health Group","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoling","family":"Feng","sequence":"additional","affiliation":[{"name":"Kite, a Gilead company","place":["Santa Monica, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Mayo Clinic","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-4571","authenticated-orcid":false,"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center","place":["New York, USA"]},{"name":"Department of Medicine, Weill Cornell Medical College","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301665"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.08.010"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016747"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.10.016"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2021.88737"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.10.015"},{"key":"e_1_3_6_9_1","unstructured":"NICE. Final appraisal document: axicabtagene ciloleucel for treating relapsed or refractor diffuse large B-cell lymphoma after first-line chemoimmunotherapy. 2023."},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.013"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.01.008"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.02.007"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e20021"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00315"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.06.009"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.45956"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00478"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27075"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1529674"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06290495"},{"key":"e_1_3_6_22_1","unstructured":"NICE. Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies [TA567]. Technology appraisal guidance. London: National Institute for Health and Care Excellence; 2019."},{"key":"e_1_3_6_23_1","unstructured":"RED BOOK. 2023. [cited 20021 Nov 1]. Available from: https:\/\/www.ibm.com\/products\/micromedex-red-book."},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1901721"},{"key":"e_1_3_6_25_1","unstructured":"Centers for Medicare and Medicaid Services. Physician fee schedule 2023 [cited 2023 Mar 31]. Available from: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched."},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000164543.14619.00"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.2373.2373"},{"issue":"7","key":"e_1_3_6_28_1","first-page":"366","article-title":"The cost of hematopoietic stem-cell transplantation in the United States","volume":"10","author":"Broder MS","year":"2017","unstructured":"Broder MS, Quock TP, Chang E, et\u00a0al. The cost of hematopoietic stem-cell transplantation in the United States. Am Health Drug Benefits. 2017;10(7):366\u2013374.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600573325"},{"key":"e_1_3_6_30_1","unstructured":"Surveillance EaERP. Cancer stat facts: NHL - diffuse large B-cell lymphoma (DLBCL). 2021. [cited 2021 Nov 1]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/dlbcl.html."},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5866"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.498"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2023.2290832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:43:21Z","timestamp":1772779401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2023.2290832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/13696998.2023.2290832"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2023.2290832","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}